Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors	Advanced Solid Tumor (Phase 1)	Not yet recruiting	Phase 1	2026-02-25		NCT07434609

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanolattix Biotechnology Co., Ltd.	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials